MPN-RC Monthly Publication

Title:Splenic extramedullary hematopoiesis in myelofibrosis is shaped by transcriptomic and epigenetic dysregulation

Authors: Rebecca Austin, Madeline H. Kowalski, Xiaoli Wang, Ziyan Lin, Bettina Nadorp, Nicholas Ward, Pier Edorado Rovatti, Audrey Lasry, Zhengxi Sun, Julia Rojo-Tomillo, Giovanni Gambi, Tejas Patel, Hua Zhou, MD Babu Mia, Eduardo Esteva, Igor Dolgalev, Valeria Mezzano, Suhita Ray, Sergei Doulatov, Tatyana Gindin, Sanam Loghavi, Bethan Psaila, Aristotelis, Rahul Satija, Iannis Aifantis, Ronald Hoffman

Consortium Member of the Month

Our consortium member of the month for the month of October goes to Victoria Rivera from Mount Sinai Health System!

Victoria Rivera, MS, MBA (Vickie)

Program Manager I

It is with immense pleasure that we nominate Victoria Rivera as our Consortium Member of the Month.

There is so much that Vickie does behind the scenes to keep the MPN-RC moving forward, often taking on responsibilities that extend well beyond her formal role. She has become an indispensable part of our team, consistently anticipating what is needed and stepping in without hesitation. Vickie has built the MPN-RC’s entire communications presence from the ground up. She created the website and social media platforms, keeps them active and up to date, and makes sure that newsletters and announcements are delivered consistently and on time. She also created our Employee of the Month program and has thoughtfully taken ownership of ensuring that the contributions and accomplishments of our colleagues are recognized and celebrated. In fact, it has been quite a challenge to keep this nomination a secret from her! So much of what Vickie does happens behind the scenes, but its impact is felt throughout the MPN-RC. She brings initiative, dedication, generosity, and an extraordinary willingness to help to everything she takes on. We are incredibly fortunate to have her as part of our team and delighted to recognize her as our Consortium Member of the Month. Thank you so much for everything you do for the team, Vickie!

Nominated by: Dr. Ronald Hoffman, Dr. Bridget Marcellino, and Claire Borron

Vickie, thank you so much for all of the phenomenal work you have done for the consortium.

Keep up the great work!

ASH Conference 2025

ASH Abstracts

  • Marina Kremyanskaya, MD,PhD

    Phase II study of reparixin in patients with myelofibrosis. myeloproliferative neoplasms research consortium (MPN-RC) 120 trial

  • John Crispino, PhD,MBA

    Menin inhibition as a new therapeutic option for the myeloproliferative neoplasms

  • John Mascarenhas, MD

    Bone marrow adipocytes (BMA) as a novel biomarker of molecular response in patients with essential thrombocythemia (ET) and polycythemia vera (PV) treated with pegylated interferon alfa-2A

  • Andrew Kuykendall, MD

    A phase 2 study of canakinumab in patient with myelofibrosis: Results from part 1

  • Min Lu, MD,PhD

    Myelofibrosis stem cell fitness requires microenvironmental cell interactions

  • Xiaoli Wang, MD,PhD

    Therapy resistance and disease relapse in patients with MPN-blast phase are associated with clonal evolution and transcriptomic changes in MPN- blast phase stem cells

  • MD Babu Mia, PhD

    Single cell transcriptional profiling reveals distinct subsets of human megakaryocytes in myelofibrosis